Gyertyán I - Search Results

1

Shock priming enhances the efficacy of SSRIs in the foot shock-induced ultrasonic vocalization test.

Kassai F, Gyertyán I. Kassai F, et al. Among authors: gyertyan i. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan 10;36(1):128-35. doi: 10.1016/j.pnpbp.2011.10.012. Epub 2011 Oct 25. Prog Neuropsychopharmacol Biol Psychiatry. 2012. PMID: 22041499

2

Corrigendum: Intracerebroventricularly Injected Streptozotocin Exerts Subtle Effects on the Cognitive Performance of Long-Evans Rats.

Gáspár A, Hutka B, Ernyey AJ, Tajti BT, Varga BT, Zádori ZS, Gyertyán I. Gáspár A, et al. Among authors: gyertyan i. Front Pharmacol. 2023 Jan 5;13:1122260. doi: 10.3389/fphar.2022.1122260. eCollection 2022. Front Pharmacol. 2023. PMID: 36686687 Free PMC article.

3

mCPP-induced anxiety in the light-dark box in rats--a new method for screening anxiolytic activity.

Bilkei-Gorzó A, Gyertyán I, Lévay G. Bilkei-Gorzó A, et al. Among authors: gyertyan i. Psychopharmacology (Berl). 1998 Apr;136(3):291-8. doi: 10.1007/s002130050568. Psychopharmacology (Berl). 1998. PMID: 9566815

4

Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats.

Laszy J, Laszlovszky I, Gyertyán I. Laszy J, et al. Among authors: gyertyan i. Psychopharmacology (Berl). 2005 May;179(3):567-75. doi: 10.1007/s00213-004-2096-z. Epub 2004 Dec 24. Psychopharmacology (Berl). 2005. PMID: 15619116

5

Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression.

Kassai F, Schlumberger C, Kedves R, Pietraszek M, Jatzke C, Lendvai B, Gyertyán I, Danysz W. Kassai F, et al. Among authors: gyertyan i. Behav Pharmacol. 2012 Aug;23(4):397-406. doi: 10.1097/FBP.0b013e3283565248. Behav Pharmacol. 2012. PMID: 22785385

6

Interactions of CB1 and mGlu5 receptor antagonists in food intake, anxiety and memory models in rats.

Varga B, Kassai F, Gyertyán I. Varga B, et al. Among authors: gyertyan i. Pharmacol Biochem Behav. 2012 Dec;103(2):425-30. doi: 10.1016/j.pbb.2012.09.016. Epub 2012 Sep 28. Pharmacol Biochem Behav. 2012. PMID: 23026059

7

Cariprazine (RGH-188), a D₃-preferring dopamine D₃/D₂ receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats.

Román V, Gyertyán I, Sághy K, Kiss B, Szombathelyi Z. Román V, et al. Among authors: gyertyan i. Psychopharmacology (Berl). 2013 Mar;226(2):285-93. doi: 10.1007/s00213-012-2906-7. Epub 2012 Nov 9. Psychopharmacology (Berl). 2013. PMID: 23138433

8

Chronic escitalopram treatment attenuated the accelerated rapid eye movement sleep transitions after selective rapid eye movement sleep deprivation: a model-based analysis using Markov chains.

Kostyalik D, Vas S, Kátai Z, Kitka T, Gyertyán I, Bagdy G, Tóthfalusi L. Kostyalik D, et al. Among authors: gyertyan i. BMC Neurosci. 2014 Nov 19;15:120. doi: 10.1186/s12868-014-0120-8. BMC Neurosci. 2014. PMID: 25406958 Free PMC article.

9

Effect of a kynurenic acid analog on home-cage activity and body temperature in rats.

Kassai F, Kedves R, Gyertyán I, Tuka B, Fülöp F, Toldi J, Lendvai B, Vécsei L. Kassai F, et al. Among authors: gyertyan i. Pharmacol Rep. 2015 Dec;67(6):1188-92. doi: 10.1016/j.pharep.2015.04.015. Epub 2015 May 9. Pharmacol Rep. 2015. PMID: 26481540

10

Pharmacological comparison of traditional and non-traditional cannabinoid receptor 1 blockers in rodent models in vivo.

Varga B, Kassai F, Szabó G, Kovács P, Fischer J, Gyertyán I. Varga B, et al. Among authors: gyertyan i. Pharmacol Biochem Behav. 2017 Aug;159:24-35. doi: 10.1016/j.pbb.2017.06.012. Epub 2017 Jun 27. Pharmacol Biochem Behav. 2017. PMID: 28666894

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters